Wainstok de Calmanovici R, Ríos de Molina M C, Taira de Yamasato M C, Tomio J M, San Martin de Viale L C
Biochem J. 1984 Mar 15;218(3):753-63. doi: 10.1042/bj2180753.
The effect of a pretreatment with phenobarbitone (PB) on the porphyrinogenic action exerted by hexachlorobenzene (HCB) was examined in female rats. Kinetic studies of enzyme function after HCB poisoning showed that porphyrinogen carboxy-lyase was the only enzyme of haem biosynthesis that markedly lowered its activity. Both stages of uroporphyrinogen (UPG) III decarboxylation were decreased. This enzyme, together with UPG I synthase (increased levels) were the first enzymes altered. Subsequently, an increase in delta-aminolaevulinate (AmLev) synthase and ferrochelatase was detected; AmLev dehydratase was the last to increase. On long-term exposure, PB alone did not modify the basal values of haem intermediates; only the content of cytochrome P-450 increased. All the enzyme activities studied showed no significant changes, except ferrochelatase, which increased. With both drugs the metabolic impairment promoted by HCB was accelerated and enhanced by prior PB treatment leading to the onset of an earlier and stronger porphyria. A more noticeable accumulation and excretion of higher carboxylated porphyrins and precursors was more promptly observed as a consequence of the early porphyrinogen carboxy-lyase blockade and the concomitant induction of AmLev synthase. Although the enzymic activities of both AmLev dehydratase and ferrochelatase were enhanced, this response differed in time. For UPG I synthase this pretreatment elicited lower values than those found in the HCB group. Cytochrome P-450 contents were immediately and slightly enhanced by all the drugs, but the values for the combined treatment were the lowest. Of the several hypotheses that could explain the action of HCB on the haem pathway, our results would suggest that the porphyrinogenic action of HCB is mediated by some of its metabolic products.
在雌性大鼠中研究了苯巴比妥(PB)预处理对六氯苯(HCB)致卟啉生成作用的影响。HCB中毒后酶功能的动力学研究表明,卟啉原羧基裂解酶是血红素生物合成中唯一活性显著降低的酶。尿卟啉原(UPG)III脱羧反应的两个阶段均降低。该酶与UPG I合酶(水平升高)是最早发生改变的酶。随后,检测到δ-氨基乙酰丙酸(AmLev)合酶和亚铁螯合酶增加;AmLev脱水酶是最后增加的。长期暴露时,单独使用PB不会改变血红素中间体的基础值;只有细胞色素P-450的含量增加。除亚铁螯合酶增加外,所研究的所有酶活性均无显著变化。两种药物同时使用时,PB预处理加速并增强了HCB所致的代谢损害,导致更早、更强的卟啉症发作。由于早期卟啉原羧基裂解酶被阻断以及同时诱导AmLev合酶,更迅速地观察到了更高羧化卟啉及其前体的更明显积累和排泄。尽管AmLev脱水酶和亚铁螯合酶的酶活性均增强,但这种反应在时间上有所不同。对于UPG I合酶,这种预处理引起的值低于HCB组。所有药物均使细胞色素P-450含量立即轻微增加,但联合治疗组的值最低。在几种可以解释HCB对血红素途径作用的假说中,我们的结果表明,HCB的致卟啉生成作用是由其某些代谢产物介导的。